LB-208 for Relapsed Solid Tumors and Lymphoma

We are testing a new medication for adults with solid tumors or lymphoma that have not responded to other treatments. This study aims to evaluate its safety and potential effectiveness.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Universitari Vall D Hebron
Oncology
Barcelona, Spain
Sponsor: Leukos Biotech S.L.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.